Skip to main content

GLP-1 Agonist Therapy

Meaning

GLP-1 Agonist Therapy involves the clinical administration of pharmaceutical compounds that selectively activate the Glucagon-Like Peptide-1 (GLP-1) receptor, primarily used for the effective management of Type 2 Diabetes Mellitus and increasingly for chronic weight management. These therapeutic agents are synthetic mimetics of the endogenous incretin hormone GLP-1, engineered for enhanced stability and a significantly prolonged duration of action compared to the natural peptide. This therapeutic class is distinguished by its glucose-dependent action and favorable cardiometabolic profile.